公司简介
公司业务介绍
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
员工规模及业务情况
With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2025, WuXi Biologics is supporting 864 integrated client projects, including 24 in commercial manufacturing.
公司理念与目标
WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.
投递方式
方式：线上宣讲会
招聘要求
岗位信息
共 1 类薪酬福利
高强度培训
High-intensity training with world-class software engineering and AI leaders
实践经验
Hands-on experiences in applying software engineering and AI to cutting-edge problems across drug discovery, development and manufacturing
创新机会
Opportunities to incubate and build innovative 0 to 1 digital applications
生态资源
Access to first-class biotech and life sciences ecosystem across the globe with 300+ start-ups and companies
职业发展
Fast track to global leadership roles across Asia, US and EU
学术项目
Access to world-class academic programs (WuXi Biologics collaboration with Tsinghua University)